LabAid launched digital 3D mammograms for the first time in Bangladesh.

LabAid launched digital 3D mammograms for the first time in Bangladesh. Recently, the first digital 3D mammogram (breast tomosynthesis) was launched in Bangladesh at the LabAid Cancer Hospital and Super Specialty Center. The country was informed about this facility through a special press conference. They also officially launched their app at the ceremony.  Recently, LabAid Cancer Hospital and Super Specialty Center launched a digital 3D mammogram (Breast Tomosynthesis) for the very first time in Bangladesh. A special conference was arranged to announce this n... Learn More

Study Investigates Possible Link Between Prostate Cancer Treatment and Alzheimer's Disease

Study Investigates Possible Link Between Prostate Cancer Treatment and Alzheimer's Disease A group of researchers from the Medical College of Georgia at Augusta University are trying to find out why most of the prostate cancer patients end up with Alzheimer’s disease.One in every eight men is at risk of developing prostate cancer in their lifetime.They are researching to understand the standard hormone therapy treatment or an overactive immune response, which is responsible for this disease state.Qin Wang, MD/PhD, Georgia Research Alliance Eminent Scholar in Neurodegeneration an... Learn More

Nucleic acids found in food have the potential to inhibit the growth of cancer cells

Nucleic acids found in food have the potential to inhibit the growth of cancer cells The whole world is trying to find an effective way to fight against cancer. Scientists are trying to find a link between diet and health that will work against cancer. Finally, they enlightened us with a new hope!According to findings published in PLOS ONE by Osaka Metropolitan University Associate Professor Akiko Kojima-Yuasa of the Graduate School of Human Life and Ecology and colleagues, compounds derived from nucleic acid can inhibit the growth of cancer cells.We all know that nucleic acids... Learn More

GLP-1 Medications Lower Cancer Risk for Diabetes Patients

GLP-1 Medications Lower Cancer Risk for Diabetes Patients GLP-1 medications lower the cancer risk of 10 common obesity related cancers for diabetes patients, according to research published in JAMA Network Open on July 5, 2024.In this study, the researchers used electronic health records (EHRs) of 113 million patients of US who were prescribed GLP-1 RAs, insulin, or metformin between 2005 and 2018.Glucagon-like peptide 1 (GLP-1) receptor agonists are more effective to reduce the obesity related cancer risk among type 2 diabetes patients than insulin do... Learn More

Certain patients with metastatic solid tumors may benefit from immunotherapy

Certain patients with metastatic solid tumors may benefit from immunotherapy According to a report published in Nature Medicine on July 11, 2024, immunotherapy shows some potential effects for certain patients with metastatic solid tumors. Researchers from the National Institutes of Health (NIH) ran a trial with some metastatic colorectal cancer patients. These patients have previously tried various treatment options. The researchers used the lymphocytes of the affected cancer patients. They genetically engineered these to make some receptors in the body. These receptors... Learn More